| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Bezafibrate | Bezafibrate EP Impurity A | VL3930001 | View CAS 41859-57-8 |
| Bezafibrate | Bezafibrate EP Impurity C | VL3930003 | View CAS 2157488-46-3 |
| Bezafibrate | Bezafibrate EP Impurity D | VL3930004 | View CAS 41859-58-9 |
| Bezafibrate | Bezafibrate EP Impurity E | VL3930005 | View CAS 2732346-94-8 |
| Catalogue No. | VL3930003 |
| CAS No. | 2157488-46-3 |
| Molecular Formula | C20H22ClNO4 |
| Molecular Weight | 375.85 |
| Parent drug | Bezafibrate |
| IUPAC Name | Methyl 2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoate |
| Synonyms | N/A |
| References | “Sci-Hub, Dual and Pan-Peroxisome Proliferator-Activated Receptors (PPAR) Co-Agonism: The Bezafibrate Lessons, 10.1186/1475-2840-4-14.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1186/1475-2840-4-14. |
| Status | In-stock |
| ListName | Bezafibrate EP Impurity C |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
